Polymeric cloak stabilizes cytokine complex to generate tumor-targeted nanosuperagonist

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: A group led by Prof. Horacio Cabral has discovered a new method to construct protein complex-based therapeutics. Prof. Cabral is a visiting scientist from the Innovation Center for NanoMedicine (iCONM), and is Associate Professor of the Department of Bioengineering, Graduate School of Engineering, University of Tokyo. The paper, titled "Nano-enabled IL-15 superagonist via conditionally stabilized protein-protein interactions eradicates solid tumors by precise immunomodulation," was published...